Question

Which of the following statements is NOT true regarding Atropine in ACLS protocols.

a) Atropine can not be given through endotracheal tube
b) Atropine is the first drug for symptomatic sinus bradycardia
c) Avoid using Atropine in hypothermic bradycardia
d) Doses of atropine <0.5 mg may result in paradoxical slowing of heart ratee) Adult dose of Bradycardia (with or without ACS) 0.5 mg IV every 3 to 5 minutes as needed, not to exceed a total dose of 0.04 mg/kg (total 3 mg)

Answer 1

The statement that is NOT true regarding Atropine in ACLS protocols is avoid using Atropine in hypothermic bradycardia.

Step-by-step explanation:

The statement that is NOT true regarding Atropine in ACLS protocols is b) Avoid using Atropine in hypothermic bradycardia.

Atropine is commonly used in ACLS (Advanced Cardiovascular Life Support) protocols to treat symptomatic sinus bradycardia. It is the first drug of choice for this condition.

Atropine can be given through an endotracheal tube, but it is not the preferred route of administration. The recommended adult dose for bradycardia is 0.5 mg IV every 3 to 5 minutes as needed, not to exceed a total dose of 0.04 mg/kg (total 3 mg). Small doses (<0.5 mg) of atropine may result in paradoxical slowing of heart rate.